Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor, covering 2022-11-14 to 2022-11-14. Get the full timeline:
Most recent: Clinical Trial Update: Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer [Phase 2, Phase 3]